Press Releases
-
Silver medal from EcoVadis underlines Tower Cold Chain’s sustainability drive
Tower Cold Chain, a leading provider of pharmaceutical temperature-controlled containers, has been awarded the prestigious silver medal from EcoVadis in recognition of the continuing action made by the company towards its sustainability credentials.
Jan 4, 2023
-
Tower’s latest container available for free demonstrations
Tower Cold Chain’s latest product for smaller pharmaceutical shipments, the KTEvolution container offering protection, security, and visibility in a small box, is now available for demonstration globally, at the company’s Centres of Excellence in the EMEA, APAC and Americas regions.
Jan 4, 2023
-
Clinical trial platform provider encapsia welcomes new COO
Clinical trial management solutions provider, encapsia, has announced the appointment of Francis Destin as its new Chief Operating Officer.
Jan 4, 2023
-
Creative Diagnostics Expands Its Monoclonal Antibodies Offering to Customers
Creative Diagnostics expanded its monoclonal antibodies capabilities and offerings to global customers.
Jan 4, 2023
-
CD Bioparticles Introduces Hydrophobic Interaction Chromatography Resins for Purification of Macromolecules
CD Bioparticles launched a range of hydrophobic interaction chromatography resins for the purification of macromolecules including adeno-associated viruses.
Jan 4, 2023
-
STEMart Introduces API Impurity Identification Services for Medical Devices
STEMart has recently introduced API Impurity Identification services for global clients.
Jan 4, 2023
-
Abzena hires Matthew Stober to lead the company through the next phase of global growth
Matthew Stober hired as CEO and joins Abzena Board. Abzena continues growth as the leading provider of development and manufacturing services for Antibody Drug Conjugate (ADC) and complex biologics. Board enhanced with CDMO and Biologics industry luminaries to support future growth.
Jan 3, 2023
-
Curebase Celebrates Year of Growth, Organizational Maturity
Curebase Celebrates Year of Growth, Organizational Maturity
Jan 3, 2023
-
Nearly 480 Cosmetic Ingredients Are Now Available for Research Use
-
Creative Biogene Has Established More Than 50 Engineered Zebrafish Models to Support Human Cancer Research
-
Microbiosci Develops Microbial Cell Line Generation for Therapeutics and Diagnostic Applications
-
Creative Biogene Has Developed GMP Lentivirus Production Service to Accelerate Cell Therapy and Gene Therapy
-
Histobiolab Releases Over 150 FISH Probes for Hematology, Pathology and Constitutional Cytogenetics
-
Acroscell Provides Customized Ionic Channel Expression System to Satisfy Screening Needs
-
Creative Bioarray Develops Cell Culture Media Solutions for Biological and Pharmaceutical Research
-
BOC Sciences Reports Its Antibody Modification and Conjugation Technologies in Detail
The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody modification and conjugation technologies, bringing the audience and customers a better understanding of how BOC Sciences has contributed to the ADC industry.
Dec 27, 2022
-
BOC Sciences Rolled Out PEG GMP Manufacture Services for Broad Applications
BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG products for a wide scope of applications.
Dec 27, 2022
-
Digi-Tech Pharma & AI 2023 (10 - 11 May 2023)
Emergence of Digital Technologies in Pharmaceutical Industry” Conference, Expo
May 9, 2023
-
CD ComputaBio Releases AutoDock Vina Software to Accelerate Molecular Docking Projects
-
Analyzing Protein Structures with Pronalyse’s Hydrogen Deuterium Exchange Mass Spectrometry